ACP-DPE: A Dual-Channel Deep Learning Model for Anticancer Peptide Prediction

Guohua Huang1,2, Yujie Cao1, Qi Dai3

  • 1College of Information Science and Engineering, Shaoyang University, Shaoyang, China.

IET Systems Biology
|March 22, 2025
PubMed

Insights

A new deep learning method, ACP-DPE, accurately predicts anticancer peptides (ACPs) for cancer treatment. This computational approach aids in identifying effective ACPs, offering a promising tool for cancer therapy research.

Area of Science:

  • Biochemistry
  • Computational Biology
  • Oncology

Background:

  • Cancer is a leading global cause of death due to uncontrolled cell growth.
  • Anticancer peptides (ACPs) show promise for cancer treatment due to lower toxicity.
  • Experimental identification of ACPs is limited by conditions and cost.

Purpose of the Study:

  • To develop a computational method for predicting anticancer peptides (ACPs).
  • To address the challenges in experimental identification of ACPs.
  • To enhance the discovery of novel ACPs for cancer therapy.

Main Methods:

  • Proposed a dual-channel deep learning model, ACP-DPE.
  • Utilized a bi-directional gated recurrent unit (Bi-GRU) for sequence dependencies.
  • Employed a dilated convolution module for local amino acid relationships.

Main Results:

  • ACP-DPE achieved 82.81% accuracy and 86.63% sensitivity.
  • The model outperformed the state-of-the-art method by 3.86% in accuracy and 5.1% in sensitivity.
  • Demonstrated the computational effectiveness of the dual-channel approach.

Conclusions:

  • ACP-DPE is an effective tool for anticancer peptide prediction.
  • The deep learning method shows significant potential in cancer treatment research.
  • Computational prediction can accelerate the discovery of therapeutic peptides.

Related Concept Videos